The largest database of trusted experimental protocols

Cd3 cd28 dynabead

Manufactured by Thermo Fisher Scientific
Sourced in United States, Germany, Switzerland, Norway, United Kingdom

CD3/CD28 Dynabeads are a type of magnetic beads coated with antibodies against the CD3 and CD28 T cell surface markers. These beads are used to activate and expand T cells in vitro for various research and therapeutic applications.

Automatically generated - may contain errors

277 protocols using cd3 cd28 dynabead

1

Generation of CD70-CAR T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CD70-CAR T cells were generated as our previous publication (22 (link)). Briefly, CD70 and CD19 CAR contain a humanized 41D12-based scFv or FMC63 mAb, respectively, followed by the CD8α-based extracellular spacer and transmembrane domains with 41BB-CD3ζ intracellular signaling domain. CD3+ T cells were purified from peripheral blood mononuclear cells (PBMNCs) of healthy donors and were activated with CD3/CD28 dynabeads (Gibco, USA), which were then transfected with lentivirus encoding CD70 or CD19 CAR with 10 μg/mL polybrene (Sigma, Germany) at a multiplicity of infection of 20 (Sigma, Germany). The CD3/CD28 dynabeads were removed on days 3-5, and the transfected T cells were expanded in AIM-V (Gibco, USA) medium supplemented with 10% FBS (Gibco, Australia), 300 IU/mL IL-2, 5 ng/mL IL-7 and IL-15 for approximately 10 days.
+ Open protocol
+ Expand
2

T Cell Activation and PD-L1 Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+ T cells were labelled with Cell Trace Violet (CTV) (Thermo Fisher Scientific) for 20 min and rested overnight before being stimulated for 72 hr with CD3/CD28 Dynabeads (Thermo Fisher Scientific). Jurkat.PDCD1 cells were stimulated for 24 hr with CD3/CD28 Dynabeads (Thermo Fisher Scientific). Primary or cell line T cells were co-cultured with HEK293T cells transfected with pcDNA3.1-CD274v1 or pcDNA3.1-CD274-L2A as indicated. Conditioned media from HEK293T.CD274-L2A cells, parental HEK293T cells, B-3T3.CD274-L2A cells, parental B-3T3 cells, IFN-γ-stimulated HBL-1 cells, parental HBL-1 cells, or 10 μg/mL ultra-LEAF anti-human PD-L1 antibody (29E.2A3, Biolegend) were added as indicated.
+ Open protocol
+ Expand
3

Lentiviral Transduction of Mouse and Human T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse T cells were activated by adding CD3/CD28 Dynabeads (Thermo Fisher Scientific) according to the manufacturer’s instructions and then transduced with lentiviral supernatants. Lentivirus was then added to retronectin (Takara)-coated non-tissue culture–treated plates to reach a total volume of 400 µL and mixed gently. T cells and virus were centrifuged at 1000 g for 2 hours and then incubated at 37°C. After 3 days of culture, the medium was changed to complete RPMI-1640 medium (10% FBS, 2 mM GlutaMAX, 100 µM β-mercaptoethanol, 1% penicillin/streptomycin, 50 U/mL rmIL-2).
Human T cells were stimulated by CD3/CD28 Dynabeads (Thermo Fisher Scientific) according to the manufacturer’s instructions. On day 2, T cells were plated in non-tissue culture-coated 24-well plates, and polybrene (8 µg/mL) was added to the medium. Lentiviral supernatant was first centrifuged at 1500 g for 2 hours on retronectin (Takara)-coated non-tissue culture-treated plates. T cells were then plated and centrifuged at 1000 g for 20 min and incubated at 37°C. After 3 days, the medium was changed to 45% RPMI-1640% and 45% Click’s medium containing 10% FBS and supplemented with rhIL-2 (50 U/mL), rhIL-7 (10 ng/mL), and rhIL-15 (5 ng/mL).
+ Open protocol
+ Expand
4

Murine and Human CD8+ T Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine CD8+ T cells were isolated (STEMCELL, 19853) and activated with 1 μg/mL αCD3 (eBioscience, 16-0031-86) and 2.5 μg/mL αCD28 (eBioscience,16-0281-82) for 2 days prior to subculture in the presence of 20 U/mL recombinant murine IL-2 (Peprotech, 50-813-288).
For human T cell culture, frozen negatively isolated CD8+ T cells (Hemacare, PB08NC1) were activated with CD3-CD28 Dynabeads (Gibco, 11131D) for 72 hours in the presence of 20 U/mL IL-2 (Roche, 11011456001) and 5 ng/mL IL-7 (Peprotech, 200-07) and IL-15 (Peprotech, 200-15). Cells were subcultured with fresh media and cytokines.
+ Open protocol
+ Expand
5

Isolation and Activation of Human T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To verify if FITC-YT-16 exerts a functional effect on human T cells, we assessed peptide performance on freshly isolated T cells. Briefly, human peripheral blood mononuclear cells (PBMCs) were isolated from healthy donor’s blood by density gradient centrifugation using Ficoll-Paque PLUS (GE Healthcare, Little Chalfont, Buckinghamshire, UK)). In brief, blood was diluted at 1:1 with phosphate-buffered saline (PBS), layered on Ficoll-Paque and centrifuged at 2000× g for 20 min. PBMCs were re-suspended in phosphate-buffered saline. Isolated T cells were immediately enriched by magnetic microbeads positive selection (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). For stimulating and activating T cells, isolated T cells were cultured in 6 well-plate in RPMI-1640 medium with 10% fetal bovine serum (FBS), 100 IU/mL penicillin, and 100 µg/mL streptomycin (Gibco, Life Technologies, Grand Island, NY, USA). Then inoculated with human T-activator CD3/CD28 Dynabeads (Gibco, Life Technologies, Grand Island, NY, USA, USA) at a ratio of one bead to one T cell for 24 h, supplemented with 50 IU/mL of recombinant human IL-2 (Novus Biologicals, Littleton, CO, USA).
+ Open protocol
+ Expand
6

Generation of IL-10Rα-Deficient Murine P14 CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild type (WT) P14 CD8+ T cells were isolated from splenocytes of Cas9 knock in P14 TCR transgenic mice using CD8 negative selection kit (Miltenyi Biotec) and activated using mouse T-activator CD3/CD28 Dynabeads® (Gibco / Thermo Fisher Scientific) for 24 h followed by 4-day expansion in complete RPMI medium containing IL-2 (10 ng/mL) prior to use. To generate control and IL-10Rα-KO P14 CD8+ T cells, WT P14 CD8+ T cells were isolated and activated for 24 h similarly, followed by transduction with retroviruses containing scramble control guide RNA (gRNA) or IL-10Rα-targeting gRNA on plates coated with RetroNectin (5 μg/cm2, Clonetech / Takara). Transduced CD8+ T cells were then expanded similarly for additional 4 days prior to use. The pool of gRNAs targeting IL-10Rα (IL-10Rα1: 5’-TCTGGCTTCAAACCACACAT-3’, IL-10Rα2: 5’-GCAGTGTTTACTTATCACGA-3’, IL-10Rα3: 5’-GTGGGGACAACACGGACAGT-3’) and a scramble control gRNA control (5’-GCGAGGTATTCGGCTCCGCG-3’) were designed using the publicly available online gRNA design tool CRISPick54 (link).
+ Open protocol
+ Expand
7

Transducing T cells with Retroviral Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells isolated from PBMCs were stimulated with CD3/CD28 Dynabeads (Gibco, Cat#11 132D) for 24 hours. T cells were transduced with retroviral constructs containing tdTomato and click beetle red luciferase in RetroNectin (Takara Bio, #Cat T100A/B)-coated six-well plates in the presence of IL-2 (100 IU/mL) and protamine sulfate (4 µg/mL). Transduced T cells were cultured for 8 days before use in animal experiments.
+ Open protocol
+ Expand
8

Cytolysis Assay for Bispecific Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-468 cells were maintained in DMEM (Corning) supplemented with 10% FBS (Corning) and 1% penicillin/streptomycin (ThermoFisher). Healthy human T cells were obtained from the Human Immunology Core (University of Pennsylvania) and expanded as previously described.26 (link) Briefly, CD4 and CD8 T cells were incubated 1:1 and stimulated with CD3/CD28 Dynabeads (Gibco). Human IL-2 (Gibco) was maintained at a concentration of 50 IU/mL for 10 days. The Dynabeads were removed after 7 days of culturing, and the cells were maintained at 0.5–1 M/mL an additional 7 days. The cells were frozen down using a 1:1 mixture of X-VIVO media (Lonza) and 10% DMSO in FBS and allowed to rest in RPMI media (Corning) supplemented with 10% FBS and 1% penicillin/streptomycin 24 hours before cytolysis assays.
10,000 tumor cells were seeded per well 24 hours prior to adding BsAb treatments and T cells at an E:T ratio of 10:1. Controls included 3-fold serial dilutions starting at 100 nM or 10 nM of the monoclonal antibodies alone (Cetuximab and OKT3 separately) and an equimolar mixture of Cetuximab and OKT3. Tumor cytolysis was tracked up to 72 hrs post-treatment using xCelligence Real-Time Cell Analysis (ACEA Biosciences). Data were analyzed and plotted with GraphPad Prism8.
+ Open protocol
+ Expand
9

Murine T Cell Modulation by hUCB-MDSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes from NC/Nga mice were seeded at a density of 1 × 106 cells/well into 24-well plates (Falcon, Corning, NY, USA) and stimulated with CD3/CD28 DYNABEADS (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) to analyze T cell proliferation. hUCB-MDSCs were cocultured with spleen cells at ratios of 0.5:1, 0.25:1, and 0.1:1. Thereafter, cell proliferation was assessed using the Cell Trace CFSE Cell Proliferation Kit (Invitrogen, Thermo Fisher Scientific) per the manufacturer’s instructions.
To analyze T-cell differentiation, purified CD4+ T cells from NC/Nga mice were seeded at a density of 3.12 × 105 cells/well into 24-well plates (Falcon) and differentiated using the Th2 differentiation kit (STEMCELL Technologies, Vancouver, Canada) or Th17 differentiation kit (R&D systems, Minneapolis, MN, USA). hUCB-MDSCs were cocultured with CD4+ T cells at ratios of 1:1, 0.5:1, and 0.25:1. Th2 and Th17 cell cultures were incubated for 6 and 5 days, respectively, according to the manufacturer’s instructions.
+ Open protocol
+ Expand
10

Adoptive Transfer of Ribociclib-Treated CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens and lymph nodes were harvested from TRP1high CD45.1+ mice. They were crushed through 40-μm cell strainers in PBS. CD8+ T cells were isolated by negative selection using an EasySep Mouse CD8+ T cell Isolation Kit (StemCell #19853). The cells were cultured in RPMI complete containing 100 U/ml human IL-2 (Peprotech 200-02-250UG) and CD3/CD28 Dynabeads (#11456; Gibco) with or without ribociclib at 200 nM. After 48 h, 2 × 106 CD45.1+ CD8+ T cells in 150 μl of sterile PBS were transferred by tail vein injection into sex-matched CD45.2+ C57BL/6 recipient mice, with half of the mice receiving cells that had been activated in the presence of ribociclib. For the longitudinal monitoring of cell persistence after transfer, mice were bled in the indicated intervals, and flow cytometry was performed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!